DEF: Integral Acquisition Seeks Fourth Extension for Business Combination
Proxy Statement for Extension
Integral Acquisition Corporation 1 is seeking stockholder approval to extend its deadline to complete a business combination from November 5, 2025, to November 5, 2026, marking its fourth such extension request.
Summary
- A special meeting of stockholders is scheduled for October 31, 2025, to vote on two proposals: the Fourth Extension Amendment Proposal and the Adjournment Proposal.
- The Fourth Extension Amendment Proposal aims to amend the company's charter to extend the deadline for completing a Business Combination from November 5, 2025, to November 5, 2026, on a monthly basis.
- Public stockholders have the right to redeem their Public Shares for cash at an approximate per-share price of $11.65 (as of October 10, 2025, before taxes) if the extension is approved and implemented.
- The company's sponsor, Integral Sponsor LLC, and its designees have agreed to loan $0.05 per non-redeemed Public Share per month to the Trust Account if the extension is approved and implemented.
- The Sponsor, directors, and officers collectively own approximately 87.3% of the outstanding Common Stock and intend to vote in favor of both proposals, ensuring their approval.
- The company's securities were delisted from Nasdaq on November 11, 2024, and are now quoted on the Pink Open Market of the OTC.
- A previously announced business combination with Flybondi was mutually terminated on June 4, 2025.
- As of October 10, 2025, the Trust Account holds approximately $4,226,391.
- The closing price of the Class A Common Stock on October 9, 2025, was $10.40.
- The company has paid U.S. federal excise taxes on previous redemptions, totaling $1,076,073 for 2023 and $97,300 for 2024.
Sentiment
Score: 2
Explanation: The company is seeking its fourth extension, has been delisted from Nasdaq, and terminated a previously announced business combination. The Trust Account has significantly depleted due to high redemptions, and the stock trades below redemption value. These factors indicate severe operational and strategic challenges, making the outlook highly negative.
Positives
- The Sponsor has committed to providing additional loans of $0.05 per non-redeemed Public Share per month to the Trust Account if the extension is approved, which would increase the per-share value for non-redeeming shareholders.
- The Board unanimously recommends voting FOR the extension, indicating their belief in the opportunity to find a suitable business combination.
- Public stockholders who do not redeem their shares now will retain their redemption rights for a future business combination vote or if no combination is completed by the new extended date.
Negatives
- This is the fourth request for an extension, indicating persistent difficulty in finding and closing a business combination.
- The company's securities were delisted from Nasdaq on November 11, 2024, and now trade on the less liquid Pink Open Market of the OTC.
- A previously announced business combination with Flybondi was terminated on June 4, 2025, after stockholders had already approved it.
- Significant redemptions occurred in previous extension votes, substantially depleting the Trust Account from an initial $116,725,000 to approximately $4,226,391 as of October 10, 2025.
- The Sponsor, directors, and officers hold approximately 87.3% of voting shares, effectively controlling the outcome of the vote, which may not align with public stockholders' interests.
- Warrants will expire worthless if a business combination is not consummated, and the Sponsor's Founder Shares and Private Placement Warrants would also become worthless.
- The company has incurred and will potentially incur further U.S. federal excise taxes on redemptions, which reduces cash available for a business combination.
- The current market price of Class A Common Stock ($10.40 on October 9, 2025) is below the redemption price ($11.65), suggesting market skepticism.
- There is no assurance that the Sponsor will make additional loans for the full term of the Fourth Extension.
- Withdrawal of funds from the Trust Account due to redemptions will reduce the amount available for a business combination, potentially requiring additional funds which may not be available on acceptable terms or at all.
Risks
- There is no assurance that the Fourth Extension will enable the company to complete a Business Combination.
- Redemptions in connection with the Fourth Extension Amendment and a subsequent Business Combination vote could leave the company with insufficient cash to consummate a Business Combination on commercially acceptable terms, or at all.
- Public stockholders may be unable to recover their investment except through sales of Public Shares on the open market, and the price of Public Shares may be volatile.
- The U.S. federal excise tax may be imposed on redemptions, reducing cash available for a Business Combination.
- Changes in laws or regulations, such as the 2024 SPAC Rules, may adversely affect the company's ability to negotiate and complete an initial Business Combination and increase related costs and time.
- The company risks being deemed an investment company under the Investment Company Act, which could impose burdensome compliance requirements and restrict its activities, making it difficult to complete an initial Business Combination.
- If the company is unable to complete an initial Business Combination, Public Stockholders may receive only approximately $11.65 per Public Share upon liquidation, and warrants will expire worthless.
- Potential target companies may be subject to review or approval by regulatory authorities (e.g., CFIUS, FCC, U.S. airline restrictions), which could delay or prevent a Business Combination.
- The Sponsor is controlled by a non-U.S. person, which may cause the company to be considered a foreign person by CFIUS, potentially limiting the pool of suitable target companies.
- Unforeseen claims of creditors could reduce the per-share distribution from the Trust Account upon liquidation.
- Stockholders may be held liable for claims by third parties against the corporation to the extent of distributions received in a dissolution if the company does not comply with certain Delaware General Corporation Law procedures.
Future Outlook
The company intends to continue actively seeking and completing a Business Combination by the Fourth Extended Date (November 5, 2026) if the extension is approved. It expects to seek stockholder approval for a Business Combination at a future meeting following the extension.
Management Comments
- "Our Board currently believes that there will not be sufficient time before the Third Extended Date to complete the Business Combination."
- "The Board believes that in order to be able to consummate the Business Combination, the Company will need to obtain the Fourth Extension."
- "The Board has determined that it is in the best interests of the Company's stockholders to extend the date by which the Company has to consummate a Business Combination to the Fourth Extended Date in order for its stockholders to have the opportunity to participate in the Company's future investment."
- "After careful consideration of all relevant factors, the Board has determined that the Fourth Extension Amendment Proposal and, if presented, the Adjournment Proposal are advisable and recommends that you vote or give instruction to vote FOR such Proposals."
Industry Context
This filing highlights the significant challenges faced by Special Purpose Acquisition Companies (SPACs) in the current market, including the difficulty in identifying and closing suitable business combinations within initial timelines. The company's repeated extension requests, coupled with its delisting from Nasdaq and the termination of a previously announced deal, are indicative of broader industry trends where many SPACs struggle to de-SPAC successfully. The impact of redemptions on trust account balances and increasing regulatory scrutiny, such as the 2024 SPAC Rules and the U.S. federal excise tax, further complicate the operating environment for SPACs.
Comparison to Industry Standards
- The company's request for a fourth extension to complete a business combination is a strong indicator of underperformance compared to successful SPACs that typically complete a deal within their initial 18-24 month timeframe or after one or two extensions at most.
- The delisting from Nasdaq to the OTC Pink Market on November 11, 2024, places the company in a less liquid and less prestigious trading environment, contrasting sharply with SPACs that successfully merge and maintain their listing on major exchanges.
- The substantial reduction of the Trust Account from $116.7 million to approximately $4.2 million due to high redemptions in prior extension votes is a severe depletion, far exceeding typical redemption rates for successful SPACs and reflecting a significant loss of investor confidence.
- The current redemption value of approximately $11.65 per share, which is higher than the Class A Common Stock's market price of $10.40, suggests that public shareholders are better off redeeming their shares rather than selling them on the open market, a common characteristic of SPACs facing liquidation or significant challenges.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Charter Amendment Proposal | Proposal to amend the company's amended and restated certificate of incorporation to extend the Business Combination deadline from November 5, 2025, to November 5, 2026. | Upon stockholder approval and filing with DE Secretary of State (if approved) | Extends the company's corporate existence and ability to pursue a business combination, but also allows for further redemptions and potential dilution of remaining public shareholders' interest. |
Related Party Transactions
- The Sponsor, Integral Sponsor LLC, owns approximately 87.3% of the outstanding Common Stock and 4,950,000 Private Placement Warrants.
- The Sponsor has provided multiple working capital loans and extension loans to the company, with over $3.2 million outstanding as of June 30, 2025, through various promissory notes.
- The company pays the Sponsor a monthly fee of $20,000 for office space, utilities, and administrative support.
- The Sponsor has agreed to indemnify the company against certain third-party claims if the Trust Account is liquidated below a specified threshold, subject to waivers.
Stakeholder Impact
- **Public Shareholders:** Those who redeem their shares can receive cash at a premium to the current market price. Those who do not redeem face continued uncertainty, potential further value erosion if no business combination is completed, and the risk of warrants expiring worthless. Their percentage interest in the company will increase if redemptions occur.
- **Sponsor and Insiders:** Their Founder Shares and Private Placement Warrants, which would otherwise expire worthless, gain another year to potentially realize value if a business combination is completed. Their outstanding loans to the company are also contingent on a successful business combination for repayment. Their voting power ensures the extension's approval.
- **Creditors:** The Sponsor has agreed to indemnify the company against certain third-party claims upon liquidation, which offers some protection, but there is no guarantee the Sponsor can satisfy these obligations. Stockholders could face liability under DGCL if proper liquidation procedures are not followed.
- **Potential Target Businesses:** The extension provides the company with more time to identify and negotiate a business combination, potentially benefiting a future target by offering a SPAC merger opportunity.
Next Steps
- Hold a Special Meeting of Stockholders on October 31, 2025, to vote on the Fourth Extension Amendment Proposal and the Adjournment Proposal.
- If the Fourth Extension Amendment Proposal is approved and implemented, file the amendment with the Delaware Secretary of State.
- Continue efforts to consummate a Business Combination by the Fourth Extended Date (November 5, 2026).
- If the extension is approved, the Sponsor will begin making monthly loans to the Trust Account starting around November 7, 2025.
- If the extension is approved, the company expects to seek stockholder approval of a Business Combination at a future meeting.
- If the Fourth Extension Amendment Proposal is not approved, or a Business Combination is not completed by November 5, 2025, the company will cease operations, redeem public shares, and liquidate.
Key Dates
| Date | Description |
|---|---|
| February 16, 2021 | Company formed under Delaware law. |
| June 14, 2021 | Initial S-1 registration statement filed with the SEC. |
| November 4, 2021 | IPO prospectus filed with the SEC. |
| November 5, 2021 | Initial Public Offering (IPO) consummated. |
| May 3, 2023 | Stockholders approved the First Extension of the Combination Period to November 3, 2023. |
| July 10, 2023 | 2023 Promissory Note issued to the Sponsor for working capital loans. |
| October 19, 2023 | Entered into the Business Combination Agreement with Flybondi Limited. |
| October 31, 2023 | Instructed Continental Stock Transfer & Trust Company to liquidate Trust Account investments to cash. |
| November 2, 2023 | Stockholders approved the Second Extension of the Combination Period to November 5, 2024. |
| November 3, 2023 | Founder Share Conversion occurred. |
| November 8, 2023 | Second Extension Promissory Note issued to the Sponsor. |
| September 12, 2024 | 2024 Promissory Note issued to the Sponsor for working capital loans. |
| October 23, 2024 | Filed 2023 Excise Tax return and paid $1,076,073 in 2023 Excise Taxes. |
| October 31, 2024 | Stockholders approved the Third Extension of the Combination Period to November 5, 2025. |
| November 4, 2024 | Received letter from Nasdaq Staff regarding delisting. |
| November 6, 2024 | Third Extension Promissory Note issued to the Sponsor. |
| November 11, 2024 | Securities delisted from Nasdaq and began trading on the Pink Open Market of the OTC. |
| March 7, 2025 | Definitive proxy statement/prospectus for Flybondi Business Combination filed. |
| March 21, 2025 | Form 25-NSE filed with the SEC, removing securities from listing and registration on Nasdaq. |
| March 28, 2025 | Stockholders approved Charter amendment and the Flybondi Business Combination Agreement at the 2025 Special Meeting. |
| April 30, 2025 | Filed 2024 Excise Tax return. |
| June 4, 2025 | Entered into a Mutual Termination Consent with Flybondi, terminating the Business Combination Agreement. Paid $97,300 in 2024 Excise Taxes. |
| September 30, 2025 | Record Date for the upcoming Special Meeting of Stockholders. |
| October 9, 2025 | Closing price of Class A Common Stock on the Pink Open Market of the OTC was $10.40. |
| October 10, 2025 | Proxy Statement dated. Trust Account balance approximately $4,226,391, with a pro rata redemption price of approximately $11.65 per Public Share. |
| October 14, 2025 | Proxy Statement first mailed to stockholders. |
| October 29, 2025 | Deadline for Public Stockholders to tender shares for redemption (5:00 p.m. Eastern time). |
| October 30, 2025 | Deadline to vote online (11:59 p.m. Eastern time). |
| October 31, 2025 | Special Meeting of Stockholders to be held (4:00 p.m. Eastern time). |
| November 5, 2025 | Current deadline for completing a Business Combination (Third Extended Date). |
| November 6, 2025 | Commencement date for monthly loans from the Sponsor if the extension is approved. |
| November 7, 2025 | Expected date for the initial loan deposit into the Trust Account if the extension is approved. |
| November 5, 2026 | Proposed new deadline for completing a Business Combination (Fourth Extended Date). |
Recommendation
sellThe company is a struggling SPAC seeking its fourth extension, indicating a prolonged inability to execute its core mission. It has been delisted from Nasdaq, terminated a prior deal, and its Trust Account has been severely depleted by redemptions. The current market price ($10.40) is below the redemption value ($11.65), offering a clear exit for public shareholders at a premium to market. The high insider ownership controlling the vote, coupled with the significant risks (e.g., excise tax, investment company status, CFIUS review, no assurance of further sponsor loans), suggests a highly speculative and unfavorable investment profile. A seasoned investor would likely advise selling or redeeming to preserve capital.
Keywords
SPAC, Extension, Business Combination, Redemption, Trust Account, Proxy Statement, Corporate Governance, SEC Filing, Integral Acquisition Corporation 1, INTE, Blank Check Company, Shareholder Vote, Delisting, OTC Market, Sponsor Loans, Excise Tax, Investment Company Act, CFIUS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.